EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis

Beatrice Vilardo iD, Fabiola De Marchi iD, Davide Raineri iD, Marcello Manfredi, Veronica De Giorgis, Alen Bebeti, Lorenza Scotti, Natasa Kustrimovic, Giuseppe Cappellano iD, Letizia Mazzini, Annalisa Chiocchetti iD

Biomolecules · 2024

DOI: 10.3390/biom14060727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Beatrice Vilardo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, University of Eastern Piedmont, 28100 Novara, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Extracellular Vesicles, Proteomics, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 Research and Innovation Program, Ministero dell'Istruzione e del Merito, European Union’s Horizon 2020 Research and Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder lacking reliable biomarkers for early diagnosis and disease progression monitoring. This study aimed to identify the novel biomarkers in plasmatic extracellular vesicles (EVs) isolated from ALS patients and healthy controls (HCs). A total of 61 ALS patients and 30 age-matched HCs were enrolled in the study and the protein content of circulating EVs was analyzed by shotgun proteomics. The study was divided into a discovery phase (involving 12 ALS and 12 HC patients) and a validation one (involving 49 ALS and 20 HC patients). In the discovery phase, more than 300 proteins were identified, with 32 proteins showing differential regulation in ALS patients compared to HCs. In the validation phase, over 400 proteins were identified, with 20 demonstrating differential regulation in ALS patients compared to HCs. Notably, seven proteins were found to be common to both phases, all of which were significantly upregulated in EVs from ALS patients. Most of them have previously been linked to ALS since they have been detected in the serum or cerebrospinal fluid of ALS patients. Among them, proteoglycan (PRG)-4, also known as lubricin, was of particular interest since it was significantly increased in ALS patients with normal cognitive and motor functions. This study highlights the significance of EVs as a promising avenue for biomarker discovery in ALS. Moreover, it sheds light on the unexpected role of PRG-4 in relation to cognitive status in ALS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisExtracellular VesiclesProteomicsBiomarkersHumansMaleMiddle AgedFemaleAgedProteoglycansCognitionCase-Control StudiesAdult

Stichwörter der Autor:innen

amyotrophic lateral sclerosis (ALS)cognitioncognitive impairmentextracellular vesicles (EVs)proteoglycan 4 (PRG-4)proteomics

Substanzen

BiomarkersProteoglycans

Autor:innen und Institutionen

  • Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases-IRCAD, University of Eastern Piedmont, 28100 Novara, Italy.
  • Center for Translational Research on Autoimmune and Allergic Diseases, University of Eastern Piedmont, 28100 Novara, Italy.
  • Department of Neurology and ALS Center, University Hospital "Maggiore della Carità", 28100 Novara, Italy.
  • Department of Translational Medicine, University of Eastern Piedmont, 28100 Novara, Italy.

ORCID-Profile: Beatrice Vilardo, Fabiola De Marchi, Davide Raineri, Giuseppe Cappellano, Annalisa Chiocchetti

Förderung

  • European Union's Horizon 2020 Research and Innovation Program
  • Ministero dell'Istruzione e del Merito
  • European Union’s Horizon 2020 Research and Innovation Program
  • the Italian Ministry of Education, University and Research (MIUR) Program “Departments of Excellence 2018–2022
  • FOHN to A.C. and AGING Projects to L.M and project NODES
  • MUR—M4C2 1.5 of the PNRR

Zitieren

APA

Vilardo, B., De Marchi, F., Raineri, D., Manfredi, M., De Giorgis, V., Bebeti, A., Scotti, L., Kustrimovic, N., Cappellano, G., Mazzini, L., & Chiocchetti, A. (2024). Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis. Biomolecules. https://doi.org/10.3390/biom14060727

Vancouver

Vilardo B, De Marchi F, Raineri D, Manfredi M, De Giorgis V, Bebeti A, et al. Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis. Biomolecules. 2024. doi:10.3390/biom14060727

BibTeX
@article{Vilardo2024,
  author = {Vilardo, Beatrice and De Marchi, Fabiola and Raineri, Davide and Manfredi, Marcello and De Giorgis, Veronica and Bebeti, Alen and Scotti, Lorenza and Kustrimovic, Natasa and Cappellano, Giuseppe and Mazzini, Letizia and Chiocchetti, Annalisa},
  title = {Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14060727}
}
Kostenlos starten →